Global Tissue Engineering Research Analysis Report 2023: Market to Reach $8.9 Billion by 2028, Driven by Rising Funding and Investments and Advancements in Regenerative Medicines – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%

The growth of this market can be attributed to rising funding and investments for the development of advanced tissue engineering solutions and growing technological advancements in regenerative medicines.

In addition, increasing incidences of road accidents and trauma injuries drive the demand for tissue engineering products. The rising demand for tissue-engineered products for the treatment of chronic and degenerative diseases is promoting the growth of the market.

The synthetic material segment accounted for the largest share by material in 2022

The synthetic material segment accounted for the largest share of material in the global tissue engineering market in 2022. Various factors, such as increasing demand for innovative tissue engineering solutions for tissue repair and regeneration and growing investments and government funding for the advancement of technologies in the healthcare sector, are driving the demand for synthetic materials in the tissue engineering market. Additionally, the market share of the synthetic material market is expected to grow simultaneously with the growing demand for regenerative medicines.

The Asia Pacific region is growing in the tissue engineering market during the forecast period of 2023-2028

Increasing R&D activities and the growing adoption of advanced medical care technologies are the major factors driving the adoption of tissue engineering.

The Asia Pacific region is growing at a higher rate during the forecast period. Several factors, including the growing adoption of advanced medical care technologies and the booming healthcare industry, are propelling the growth of the tissue engineering market in the region. The increasing advancements in cell therapies and regenerative medicines are promoting the growth of the tissue engineering market in the region.

For instance, the Department of Science & Technology (DST), Government of India, Inspire fellows are developing biomaterials for bone tissue regeneration. The study focuses on the development of materials for therapeutic applications and studying properties of stem cells for tissue regeneration.

The report provides insights on the following pointers:

• Analysis of key drivers (rising funding and investments for the development of innovative tissue engineering products and growing need for tissue engineering solutions), restraints (strict regulations), opportunities (increasing technological advancements such as 3D bioprinting and organ-on-chip technology), and challenges (limited awareness for tissue engineering) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the tissue engineering market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue engineering market.

Key Attributes:

Report Attribute	Details
No. of Pages	344
Forecast Period	2023 – 2028
Estimated Market Value (USD) in 2023	$4.4 Billion
Forecasted Market Value (USD) by 2028	$8.9 Billion
Compound Annual Growth Rate	15.3%
Regions Covered	Global

List of Companies Profiled in the Report:

• Organogenesis (US)
• AbbVie Inc. (US)
• Baxter (US)
• BD (US)
• B. Braun (Germany)
• TEIJIN Limited (Japan)
• Institut Straumann AG (Switzerland)
• Integra Lifesciences (US)
• Johnson & Johnson Services, Inc. (US)
• Medtronic (Ireland)
• NuVasive, Inc. (US)
• Stryker (US)
• Terumo Corporation (Japan)
• W. L. Gore & Associates Inc. (US)
• Zimmer Biomet (US)
• Smith & Nephew plc (UK)
• MIMEDX Group, Inc. (US)
• BioTissue (US)
• CollPlant Biotechnologies Ltd. (Israel)
• Sumitomo Pharma Co., Ltd. (Japan)
• Matricel GmbH (Germany)
• Mallinckrodt (US)
• Regrow Biosciences Pvt Ltd (India)
• Vericel Corporation (US)
• Tecnoss S.R.L. (Italy)
• Tegoscience (South Korea)
• Tissue Regenix (UK)

For more information about this report visit https://www.researchandmarkets.com/r/9mpqz8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900